All Stocks
A

ABUS

Arbutus Biopharma Corporation
Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$4.48

Market Cap

$875.74M

Beta

0.74

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+128.21%
EPS Growth (YoY)+53.27%
Revenue CAGR 3Y-28.80%
P/E Ratio0.0
PEG Ratio—
FCF Yield-4.53%
Debt / Equity0.05
Interest Coverage-506.3x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for ABUS.